speb/financial-data huggingface dataset:
EMR.DE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 564100000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.07
EMR.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 605000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — EBIT: 891000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — EBITDA: 1250000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -6000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 454000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 1748000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -364000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Finished Goods: 563000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 602000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -13000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -828000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 18182000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 27387000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3096000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Gross PPE: 7101000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Gross Profit: 2311000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 193000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 116000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 116000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Interest Income: 26000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 26000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Inventory: 2353000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 33545000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -125000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 3473000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 513000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 7575000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 8088000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -587000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: 15000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Minority Interests: -1000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -250000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 11520000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income: 605000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 605000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 606000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 605000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 605000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 606000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 606000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -90000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 302000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -587000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -90000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -104000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -28000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 3507000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 889000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -7110000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 660000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 75000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1792000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 75000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 1792000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 454000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1273000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 622940000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 699000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Operating Income: 864000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 4346000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 562000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1770000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5693000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 139000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -828000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: 1000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 9205000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 36000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 220000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 793000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 24000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Other Properties: 7101000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Payables: 1532000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2915000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 461000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 775000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Raw Materials: 1790000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Receivables: 2972000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1881000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 359000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3171000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -250000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 10000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 40871000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1242000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 953400000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 3473000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -2584000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Special Income Charges: -10000000.00
EMR.DE cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 55000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 20277000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -7110000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -5060000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 169000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 41939000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 27852000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 13920000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 20292000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 3482000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 21647000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 33096000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 11127000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 193000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -23000000.00
EMR.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -23000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 391400000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 20259000000.00
EMR.DE balance_sheet (quarterly, 2025-12-31) — Working Capital: -1677000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — +Operating Expense: 1521000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 4562000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1468000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3158000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3620000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 64000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -125000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Amortization: 205000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 282000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 282000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 205000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 560100000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 1.10
EMR.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1748000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -85000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -85000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 698000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 477000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1791000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1791000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -312000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -649000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -81000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 779000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 119000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 3000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Inventory: -110000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -74000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Payable: 119000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 122000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -194000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -256000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 49000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 477000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 20303000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -292000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2140000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 1343000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Assets: 9251000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 144000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Debt: 5804000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5948000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1175000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1175000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 10654000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Current Provisions: 79000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Defined Pension Benefit: 1266000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 87000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 369000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 205000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 369000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 205000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 563000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.10
EMR.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — EBIT: 903000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — EBITDA: 1272000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -6000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 452000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 1791000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -649000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Finished Goods: 596000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 694000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -19000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -861000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1316000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 18153000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 27107000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3283000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Gross PPE: 7147000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Gross Profit: 2422000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 57000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 110000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 110000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Interest Income: 26000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 26000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Inventory: 2452000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 33662000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -81000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3001000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 554000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7555000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 8109000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: 16000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 0.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -292000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 11568000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 618000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 618000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -84000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -26000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
EMR.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -84000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -19000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 4000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 3527000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: -26000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -6804000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Accounts Receivable: 640000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 81000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1745000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 81000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1745000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 452000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 1337000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 668700000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 779000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Operating Income: 901000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 4562000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 560100000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1850000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 5804000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -861000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Other Gand A: 1316000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: -24000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 8954000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -10000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 216000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 809000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 41000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Other Properties: 7147000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Payables: 1525000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 2868000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 584000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 793000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1856000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 3158000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1976000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 369000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -3027000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -292000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 46000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 41176000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1316000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 953400000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 3001000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -3027000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -46000000.00
EMR.DE cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 58000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 20303000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -6804000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -14300000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 175000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.22
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 42088000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 27858000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 14057000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 20319000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 3661000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 21769000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 32837000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 11115000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 57000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -65000000.00
EMR.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -65000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 393300000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 20553000000.00
EMR.DE balance_sheet (quarterly, 2026-03-31) — Working Capital: -1403000000.00
EMR.L cash_flow (annual, 2021-12-31) — Cash Dividends Paid: -500000.00
EMR.L income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 300000.00
EMR.L cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
EMR.L balance_sheet (annual, 2021-12-31) — Other Current Assets: 900000.00
EMR.L balance_sheet (annual, 2021-12-31) — Other Equity Interest: -10200000.00
EMR.L balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 700000.00
EMR.L cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
EMR.L income_statement (annual, 2022-12-31) — +Operating Expense: 56600000.00
EMR.L income_statement (annual, 2022-12-31) — +Total Revenue: 261300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Accounts Payable: 2400000.00
EMR.L balance_sheet (annual, 2022-12-31) — Accounts Receivable: 33300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -20900000.00
EMR.L balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -800000.00
EMR.L income_statement (annual, 2022-12-31) — Amortization: 1400000.00
EMR.L cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 1600000.00
EMR.L income_statement (annual, 2022-12-31) — Basic Average Shares: 49400000.00
EMR.L income_statement (annual, 2022-12-31) — Basic EPS: 0.07
EMR.L cash_flow (annual, 2022-12-31) — Beginning Cash Position: 21100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 21100000.00
EMR.L cash_flow (annual, 2022-12-31) — Capital Expenditure: -2100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 7900000.00
EMR.L balance_sheet (annual, 2022-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 22300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 22300000.00
EMR.L cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -600000.00
EMR.L cash_flow (annual, 2022-12-31) — Change In Payable: -3500000.00
EMR.L cash_flow (annual, 2022-12-31) — Change In Receivables: 6900000.00
EMR.L cash_flow (annual, 2022-12-31) — Change In Working Capital: 3400000.00
EMR.L cash_flow (annual, 2022-12-31) — Changes In Cash: 500000.00
EMR.L balance_sheet (annual, 2022-12-31) — Common Stock: 2500000.00
EMR.L cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -600000.00
EMR.L balance_sheet (annual, 2022-12-31) — Common Stock Equity: 42800000.00
EMR.L cash_flow (annual, 2022-12-31) — Common Stock Payments: -400000.00
EMR.L income_statement (annual, 2022-12-31) — Cost Of Revenue: 195900000.00
EMR.L balance_sheet (annual, 2022-12-31) — Current Assets: 69000000.00
EMR.L balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Current Debt: 29700000.00
EMR.L balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 35000000.00
EMR.L balance_sheet (annual, 2022-12-31) — Current Liabilities: 69200000.00
EMR.L cash_flow (annual, 2022-12-31) — Deferred Tax: 2800000.00
EMR.L cash_flow (annual, 2022-12-31) — Depreciation: 6300000.00
EMR.L cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 7900000.00
EMR.L income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1400000.00
EMR.L income_statement (annual, 2022-12-31) — Depreciation Income Statement: 0.00
EMR.L income_statement (annual, 2022-12-31) — Diluted Average Shares: 50900000.00
EMR.L income_statement (annual, 2022-12-31) — Diluted EPS: 0.07
EMR.L income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 3400000.00
EMR.L income_statement (annual, 2022-12-31) — EBIT: 9100000.00
EMR.L income_statement (annual, 2022-12-31) — EBITDA: 17000000.00
EMR.L cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 700000.00
EMR.L cash_flow (annual, 2022-12-31) — End Cash Position: 22300000.00
EMR.L cash_flow (annual, 2022-12-31) — Financing Cash Flow: -12400000.00
EMR.L cash_flow (annual, 2022-12-31) — Free Cash Flow: 12600000.00
EMR.L income_statement (annual, 2022-12-31) — General And Administrative Expense: 55200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Goodwill: 31900000.00
EMR.L balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 40100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 34100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Gross PPE: 31200000.00
EMR.L income_statement (annual, 2022-12-31) — Gross Profit: 65400000.00
EMR.L income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
EMR.L income_statement (annual, 2022-12-31) — Interest Expense: 1500000.00
EMR.L income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1500000.00
EMR.L income_statement (annual, 2022-12-31) — Interest Income: 300000.00
EMR.L income_statement (annual, 2022-12-31) — Interest Income Non Operating: 300000.00
EMR.L cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -1500000.00
EMR.L cash_flow (annual, 2022-12-31) — Interest Received Cfi: 300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Invested Capital: 73000000.00
EMR.L cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1800000.00
EMR.L cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
EMR.L balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 2600000.00
EMR.L balance_sheet (annual, 2022-12-31) — Long Term Debt: 500000.00
EMR.L balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 3100000.00
EMR.L cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
EMR.L cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2700000.00
EMR.L balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8000000.00
EMR.L balance_sheet (annual, 2022-12-31) — Minority Interest: 6200000.00
EMR.L income_statement (annual, 2022-12-31) — Minority Interests: -1400000.00
EMR.L cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -400000.00
EMR.L balance_sheet (annual, 2022-12-31) — Net Debt: 7900000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income: 3400000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 3400000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 4800000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 3400000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 3400000.00
EMR.L cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 4800000.00
EMR.L income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 4800000.00
EMR.L income_statement (annual, 2022-12-31) — Net Interest Income: -1200000.00
EMR.L cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -5700000.00
EMR.L cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -2700000.00
EMR.L income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Net PPE: 10300000.00
EMR.L cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -2100000.00
EMR.L cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -3000000.00
EMR.L balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2700000.00
EMR.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 4400000.00
EMR.L balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 2500000.00
EMR.L income_statement (annual, 2022-12-31) — Normalized EBITDA: 17000000.00
EMR.L income_statement (annual, 2022-12-31) — Normalized Income: 3400000.00
EMR.L cash_flow (annual, 2022-12-31) — Operating Cash Flow: 14700000.00
EMR.L income_statement (annual, 2022-12-31) — Operating Income: 8800000.00
EMR.L income_statement (annual, 2022-12-31) — Operating Revenue: 261300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 49853001.00
EMR.L balance_sheet (annual, 2022-12-31) — Other Equity Interest: -10200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8200000.00
EMR.L cash_flow (annual, 2022-12-31) — Other Non Cash Items: 1200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Other Payable: 1600000.00
EMR.L balance_sheet (annual, 2022-12-31) — Other Properties: 2100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Other Receivables: 10100000.00
EMR.L income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMR.L balance_sheet (annual, 2022-12-31) — Payables: 10600000.00
EMR.L balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2400000.00
EMR.L income_statement (annual, 2022-12-31) — Pretax Income: 7600000.00
EMR.L balance_sheet (annual, 2022-12-31) — Properties: 0.00
EMR.L cash_flow (annual, 2022-12-31) — Purchase Of PPE: -2100000.00
EMR.L income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 195900000.00
EMR.L income_statement (annual, 2022-12-31) — Reconciled Depreciation: 7900000.00
EMR.L cash_flow (annual, 2022-12-31) — Repayment Of Debt: -5700000.00
EMR.L cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -400000.00
EMR.L income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
EMR.L balance_sheet (annual, 2022-12-31) — Retained Earnings: 23400000.00
EMR.L income_statement (annual, 2022-12-31) — Selling General And Administration: 55200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Share Issued: 49853001.00
EMR.L cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -3000000.00
EMR.L income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
EMR.L cash_flow (annual, 2022-12-31) — Stock Based Compensation: 300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Stockholders Equity: 42800000.00
EMR.L balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2700000.00
EMR.L income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
EMR.L income_statement (annual, 2022-12-31) — Tax Provision: 2800000.00
EMR.L income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.37
EMR.L balance_sheet (annual, 2022-12-31) — Taxes Receivable: 900000.00
EMR.L cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -4200000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Assets: 123800000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Capitalization: 43300000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Debt: 38100000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 49000000.00
EMR.L income_statement (annual, 2022-12-31) — Total Expenses: 252500000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 74800000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 54800000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 5600000.00
EMR.L income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 8800000.00
EMR.L balance_sheet (annual, 2022-12-31) — Total Tax Payable: 6600000.00
EMR.L income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
EMR.L income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
EMR.L balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 0.00
EMR.L balance_sheet (annual, 2022-12-31) — Working Capital: -200000.00
EMR.L income_statement (annual, 2023-12-31) — +Operating Expense: 53600000.00
EMR.L income_statement (annual, 2023-12-31) — +Total Revenue: 250300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Accounts Payable: 2000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Accounts Receivable: 31000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -21800000.00
EMR.L balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -800000.00
EMR.L income_statement (annual, 2023-12-31) — Amortization: 1200000.00
EMR.L cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 1200000.00
EMR.L income_statement (annual, 2023-12-31) — Basic Average Shares: 49100000.00
EMR.L income_statement (annual, 2023-12-31) — Basic EPS: -0.06
EMR.L cash_flow (annual, 2023-12-31) — Beginning Cash Position: 22300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 20400000.00
EMR.L cash_flow (annual, 2023-12-31) — Capital Expenditure: -1400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 6900000.00
EMR.L balance_sheet (annual, 2023-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 17100000.00
EMR.L balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 17100000.00
EMR.L cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -700000.00
EMR.L cash_flow (annual, 2023-12-31) — Change In Payable: -400000.00
EMR.L cash_flow (annual, 2023-12-31) — Change In Receivables: 200000.00
EMR.L cash_flow (annual, 2023-12-31) — Change In Working Capital: -200000.00
EMR.L cash_flow (annual, 2023-12-31) — Changes In Cash: -4100000.00
EMR.L balance_sheet (annual, 2023-12-31) — Common Stock: 2500000.00
EMR.L cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -700000.00
EMR.L balance_sheet (annual, 2023-12-31) — Common Stock Equity: 36400000.00
EMR.L cash_flow (annual, 2023-12-31) — Common Stock Payments: -400000.00
EMR.L income_statement (annual, 2023-12-31) — Cost Of Revenue: 192800000.00
EMR.L balance_sheet (annual, 2023-12-31) — Current Assets: 61800000.00
EMR.L balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Current Debt: 19000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 23300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Current Liabilities: 55800000.00
EMR.L cash_flow (annual, 2023-12-31) — Deferred Tax: 1400000.00
EMR.L cash_flow (annual, 2023-12-31) — Depreciation: 6900000.00
EMR.L cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 8100000.00
EMR.L income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1200000.00
EMR.L income_statement (annual, 2023-12-31) — Depreciation Income Statement: 0.00
EMR.L income_statement (annual, 2023-12-31) — Diluted Average Shares: 49800000.00
EMR.L income_statement (annual, 2023-12-31) — Diluted EPS: -0.06
EMR.L income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -2900000.00
EMR.L income_statement (annual, 2023-12-31) — EBIT: 2300000.00
EMR.L income_statement (annual, 2023-12-31) — EBITDA: 10400000.00
EMR.L cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1100000.00
EMR.L cash_flow (annual, 2023-12-31) — End Cash Position: 17100000.00
EMR.L cash_flow (annual, 2023-12-31) — Financing Cash Flow: -8800000.00
EMR.L cash_flow (annual, 2023-12-31) — Free Cash Flow: 4100000.00
EMR.L cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
EMR.L income_statement (annual, 2023-12-31) — General And Administrative Expense: 52400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Goodwill: 29700000.00
EMR.L balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 36600000.00
EMR.L balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 31800000.00
EMR.L balance_sheet (annual, 2023-12-31) — Gross PPE: 30600000.00
EMR.L income_statement (annual, 2023-12-31) — Gross Profit: 57500000.00
EMR.L income_statement (annual, 2023-12-31) — Interest Expense: 2200000.00
EMR.L income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2200000.00
EMR.L income_statement (annual, 2023-12-31) — Interest Income: 600000.00
EMR.L income_statement (annual, 2023-12-31) — Interest Income Non Operating: 600000.00
EMR.L cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -2200000.00
EMR.L cash_flow (annual, 2023-12-31) — Interest Received Cfi: 600000.00
EMR.L balance_sheet (annual, 2023-12-31) — Invested Capital: 64600000.00
EMR.L cash_flow (annual, 2023-12-31) — Investing Cash Flow: -800000.00
EMR.L cash_flow (annual, 2023-12-31) — Issuance Of Debt: 1000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2600000.00
EMR.L balance_sheet (annual, 2023-12-31) — Long Term Debt: 9200000.00
EMR.L balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 11800000.00
EMR.L cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 1000000.00
EMR.L cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 7900000.00
EMR.L balance_sheet (annual, 2023-12-31) — Minority Interest: 6500000.00
EMR.L income_statement (annual, 2023-12-31) — Minority Interests: -1600000.00
EMR.L cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
EMR.L cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Net Debt: 11100000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income: -2900000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2900000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -1300000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2900000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2900000.00
EMR.L cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -1300000.00
EMR.L income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -1300000.00
EMR.L income_statement (annual, 2023-12-31) — Net Interest Income: -1600000.00
EMR.L cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1400000.00
EMR.L cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 600000.00
EMR.L income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1600000.00
EMR.L balance_sheet (annual, 2023-12-31) — Net PPE: 8800000.00
EMR.L cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1400000.00
EMR.L cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -2000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -200000.00
EMR.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 5700000.00
EMR.L balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2400000.00
EMR.L income_statement (annual, 2023-12-31) — Normalized EBITDA: 11100000.00
EMR.L income_statement (annual, 2023-12-31) — Normalized Income: 382000.00
EMR.L cash_flow (annual, 2023-12-31) — Operating Cash Flow: 5500000.00
EMR.L income_statement (annual, 2023-12-31) — Operating Income: 3900000.00
EMR.L income_statement (annual, 2023-12-31) — Operating Revenue: 250300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 49051862.00
EMR.L balance_sheet (annual, 2023-12-31) — Other Equity Interest: -10200000.00
EMR.L balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 6900000.00
EMR.L cash_flow (annual, 2023-12-31) — Other Non Cash Items: 1700000.00
EMR.L balance_sheet (annual, 2023-12-31) — Other Payable: 1900000.00
EMR.L balance_sheet (annual, 2023-12-31) — Other Properties: 2300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Other Receivables: 10500000.00
EMR.L income_statement (annual, 2023-12-31) — Other Special Charges: -100000.00
EMR.L income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
EMR.L balance_sheet (annual, 2023-12-31) — Payables: 10900000.00
EMR.L balance_sheet (annual, 2023-12-31) — Prepaid Assets: 2000000.00
EMR.L income_statement (annual, 2023-12-31) — Pretax Income: 100000.00
EMR.L balance_sheet (annual, 2023-12-31) — Properties: 0.00
EMR.L cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1400000.00
EMR.L income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 192800000.00
EMR.L income_statement (annual, 2023-12-31) — Reconciled Depreciation: 8100000.00
EMR.L cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2400000.00
EMR.L cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -400000.00
EMR.L income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 500000.00
EMR.L balance_sheet (annual, 2023-12-31) — Retained Earnings: 19200000.00
EMR.L cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
EMR.L income_statement (annual, 2023-12-31) — Selling General And Administration: 52400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Share Issued: 49853001.00
EMR.L cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2000000.00
EMR.L income_statement (annual, 2023-12-31) — Special Income Charges: -2200000.00
EMR.L cash_flow (annual, 2023-12-31) — Stock Based Compensation: -300000.00
EMR.L balance_sheet (annual, 2023-12-31) — Stockholders Equity: 36400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Tangible Book Value: -200000.00
EMR.L income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -418000.00
EMR.L income_statement (annual, 2023-12-31) — Tax Provision: 1400000.00
EMR.L income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.19
EMR.L balance_sheet (annual, 2023-12-31) — Taxes Receivable: 1200000.00
EMR.L cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -3200000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Assets: 112900000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Capitalization: 45600000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Debt: 35100000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 42900000.00
EMR.L income_statement (annual, 2023-12-31) — Total Expenses: 246400000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 70000000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 51100000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 14200000.00
EMR.L income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1700000.00
EMR.L balance_sheet (annual, 2023-12-31) — Total Tax Payable: 7000000.00
EMR.L income_statement (annual, 2023-12-31) — Total Unusual Items: -700000.00
EMR.L income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -2200000.00
EMR.L balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 801139.00
EMR.L balance_sheet (annual, 2023-12-31) — Working Capital: 6000000.00
EMR.L income_statement (annual, 2023-12-31) — Write Off: 300000.00
EMR.L income_statement (annual, 2024-12-31) — +Operating Expense: 47800000.00
EMR.L income_statement (annual, 2024-12-31) — +Total Revenue: 246200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Accounts Payable: 2000000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 2000000.00
EMR.L balance_sheet (annual, 2024-12-31) — Accounts Receivable: 29700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 29700000.00
EMR.L balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -23800000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -23800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 22400000.00
EMR.L balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -600000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -600000.00
EMR.L income_statement (annual, 2024-12-31) — Amortization: 1200000.00
EMR.L cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 1200000.00
EMR.L income_statement (annual, 2024-12-31) — Basic Average Shares: 49100000.00
EMR.L income_statement (annual, 2024-12-31) — Basic EPS: -0.21
EMR.L cash_flow (annual, 2024-12-31) — Beginning Cash Position: 17100000.00
EMR.L balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 20700000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 20700000.00
EMR.L cash_flow (annual, 2024-12-31) — Capital Expenditure: -800000.00
EMR.L balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 6200000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 6200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Capital Stock: 2500000.00
EMR.L balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 17200000.00
EMR.L balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 17200000.00
EMR.L balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 17200000.00